Jane Hanlon
Associate Director, Investor Relations
Replay available
PTC Therapeutics, Inc. (PTCT) Q3 2023 Earnings Call
PTC Therapeutics, Inc. (NASDAQ: PTCT) Q3 2023 earnings conference call, held 2023-10-26. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Dr. Matthew Klein
Chief Executive Officer
Eric Powles
Chief Business Officer
Kylie O'Keefe
Chief Commercial Officer
Pierre Gravier
Chief Financial Officer
Eric Joseph
Analyst, JP Morgan
Kristen Kluska
Analyst, Cantor Fitzgerald
Sammy Corwin
Analyst, William Blair
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Ptc Therapeutics, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.049 -- 00:00:04.952 Thank you for standing by, and welcome to the PTC Therapeutics Third Quarter 2023 00:00:04.952 -- 00:00:08.654 Financial Resorts Conference Call. At this time, all participants are on a listen-only 00:00:08.654 -- 00:00:12.976 mode. After the speaker's presentations, there will be a question-and-answer session. 00:00:12.976 -- 00:00:17.579 To ask a question at that time, please press star 11 on your telephone. 00:00:17.579 -- 00:00:19.300 Please be advised today's call is being recorded. 00:00:19.300 -- 00:00:23.942 I will now turn the conference to your host, Jane Hanlon, Associate Director of Investor 00:00:23.942 -- 00:00:26.806 Relations. Please go ahead. 00:00:26.806 -- 00:00:31.450 Good afternoon, and thank you for joining us today to discuss PCC Therapeutics' third 00:00:31.450 -- 00:00:35.993 quarter 2023 corporate update and financial results. 00:00:35.993 -- 00:00:38.715 I'm joined today by our Chief Executive Officer, Dr. 00:00:38.715 -- 00:00:43.879 Matthew Klein, our Chief Business Officer, Eric Powles, our Chief Commercial 00:00:43.879 -- 00:00:49.144 Officer, Kylie O'Keefe, and our Chief Financial Officer, Pierre Gravier. 00:00:49.144 -- 00:00:54.591 Today's call will include forward-looking statements based on our current expectations. 00:00:54.591 -- 00:00:59.336 please take a moment to review the slide posted on our investor relations website in 00:00:59.336 -- 00:01:04.080 conjunction with the call, which contains our forward-looking statements. 00:01:04.080 -- 00:01:08.364 Our actual results could materially differ from these forward-looking statements, as 00:01:08.364 -- 00:01:13.329 such statements are subject to risks that can materially and adversely affect our business 00:01:13.329 -- 00:01:15.892 and the r...